問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
王中傑
下載
2019-04-30 - 2024-12-31
Condition/Disease
Test Drug
Participate Sites5Sites
Recruiting5Sites
2025-09-15 - 2036-04-30
Participate Sites8Sites
Recruiting8Sites
2022-05-02 - 2028-12-01
Participate Sites6Sites
Recruiting6Sites
2025-08-01 - 2032-12-31
2025-02-03 - 2033-05-03
Participate Sites4Sites
Recruiting4Sites
2023-06-03 - 2030-04-29
Not yet recruiting3Sites
Recruiting1Sites
2020-04-01 - 2024-01-10
Metastatic Castration-resistant Prostate Cancer
OPDIVO (nivolumab) Injection 10mg/mL
全部
